Back to
Fairfax Financial Holdings Ltd.
XERS
Showing 3 of 14 quarters
Position history for
Fairfax Financial Holdings Ltd.'s holdings in Xeris Biopharma Holdings, Inc.
No. Fairfax Financial Holdings exited its XERS position in Q1 2025. Its Q4 2024 13F listed 139,687 shares worth $472,142. Fairfax Financial Holdings already held XERS in its Q4 2021 13F, the earliest on record, and held it in 13 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$485,461
Total Shares Change
-170,937
Quarter-by-Quarter History